Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
266 results found
2020
Advice on the changes to the PCV13 immunization schedule
Recommendation Africa Burkina Faso Pneumococcal disease
Download:
2020 ∙ Conseil Supérieur de la Santé (CSS)
Pneumococcal vaccination for adults
Recommendation Europe Belgium Pneumococcal disease
Download:
2020 ∙ Haute Autorité de Santé
Pneumococcal vaccination in the context of supply issues and the COVID-19 epidemic in France
Recommendation Europe France Pneumococcal disease
Download:
2019 ∙ McGirr, A. Iqbal, S. M. Izurieta, P. Talarico, C. Luijken, J. Redig, J. Newson, R. S.
A systematic literature review and network meta-analysis feasibility study to assess the comparative efficacy and comparative effectiveness of pneumococcal conjugate vaccines
Newborn Children Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2019 ∙ Leidner, A. J. Murthy, N. Chesson, H. W. Biggerstaff, M. Stoecker, C. Harris, A. M. Acosta, A. Dooling, K. Bridges, C. B.
Cost-effectiveness of adult vaccinations: A systematic review
Americas United States of America Canada Adults Influenza Pneumococcal disease Human papillomavirus (HPV) Herpes zoster Hepatitis B Tetanus Diphtheria Pertussis Economic aspects
Rating:
Not applicable
2019 ∙ Sings, H. L. De Wals, P. Gessner, B. D. Isturiz, R. Laferriere, C. McLaughlin, J. M. Pelton, S. Schmitt, H. J. Suaya, J. A. Jodar, L.
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies
Newborn Children Pneumococcal disease Efficacy/effectiveness Safety Administration
Rating:
Critically low
2019 ∙ Vardanjani, H. M. Borna, H. Ahmadi, A.
Effectiveness of pneumococcal conjugate vaccination against invasive pneumococcal disease among children with and those without HIV infection: a systematic review and meta-analysis
Newborn Children Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2019 ∙ Ngocho, J. S. Magoma, B. Olomi, G. A. Mahande, M. J. Msuya, S. E. de Jonge, M. I. Mmbaga, B. T.
Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review
Africa All age groups Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2019 ∙ Adawi, M. Bragazzi, N. L. McGonagle, D. Watad, S. Mahroum, N. Damiani, G. Conic, R. Bridgewood, C. Mahagna, H. Giacomelli, L. Eggenhoffner, R. Mahamid, M. Pigatto, P. D. M. Amital, H. Watad, A.
Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: An evidence-informed and PRISMA compliant systematic review and meta-analysis
All age groups Pneumococcal disease Efficacy/effectiveness Safety
Rating:
Critically low
2019 ∙ Vadlamudi, N. K. Chen, A. Marra, F.
Impact of the 13-Valent Pneumococcal Conjugate Vaccine Among Adults: A Systematic Review and Meta-analysis
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety Administration Coverage
Rating:
Critically low
Loading...